Shijiazhuang Four Medicine Three Heavy new products were approved on the same day

Great Wall Network · Jiyun Client News (Reporter Yuan Lipeng Correspondent Wu Yuqing Shi Jian Jianhui) On June 16th, the nan -colored forest tablets, acetaminophen glycol injection, and levofloxacin injections were developed by Shijiazhuang Four Pharmaceutical Co., Ltd. This new variety has obtained a pharmaceutical registration certificate issued by the State Drug Administration.

Shijiazhuang Four Pharmaceutical Researchers in the laboratory. Data picture

Shijiazhuang Four Pharmaceuticals are approved by the Bannan Forest Forests in the fourth category of chemicals, and the remaining two injections are the third category of chemicals. They are all evaluated through consistency. Among them, the Bonan color forest tablets, which are mainly used to treat schizophrenia, are approved by domestic pharmaceutical companies; the adaptation certificate for acetaminophenolin glycol is also approved by domestic pharmaceutical companies; Levofloxacin injection is used to treat or prevent infections caused by sensitive bacteria.

Shijiazhuang Four Pharmaceutical Researchers in the laboratory. Data picture

In the past two years, Shijiazhuang Four Medicine has deployed an innovation chain around the industrial chain, and scientific and technological innovation is used as a high -quality development of strong enterprises. Enterprise R & D investment accounts for nearly 10%of the main business income, which has effectively promoted enterprises to enter the fast track of innovation and development. As of now, the company has approved a total of 20 new product projects this year, with an average of more than 3 a month. The research on generic drug innovation is at the forefront of the domestic industry. At the same time, 31 new product projects are applied for approval. The accelerated implementation of these innovative results has continuously injecting new kinetic energy into the high -quality development of enterprises, effectively promoting and pulling the structure optimization of the product chain and promotion of market levels, helping enterprises to accelerate transformation and upgrading and moving towards high -end value chain.

- END -